You are here

Article info

Article menu
Download PDFPDF
Adverse drug reactions
Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: the importance of the pharmacotherapeutic history

Authors

  1. Correspondence to Dr Miguel Fernando García-Gil, Department of Dermatology and Venerology, Lozano Blesa University Clinical Hospital, 50009 Zaragoza, Spain; miguelgarciagil{at}outlook.com
View Full Text

Citation

García-Gil MF, Lezcano Biosca V, García García M, et al
Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: the importance of the pharmacotherapeutic history
Postgraduate Medical Journal 2021;97:51-52.

Publication history

  • Received January 4, 2020
  • Revised March 3, 2020
  • Accepted March 6, 2020
  • First published March 20, 2020.
Online issue publication 
December 16, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.